Search results for "ffpe challenges"
Selected Filters:
Collaboration drives antimicrobial stewardship improvements
QPS Clinical Phase II/IV Development Services
QPSAt QPS, we realize that in today’s late stage drug development space you face many challenges. With our deep experience and broad global presence, QPS is in an excellent position to offer solutions to all of the above needs. With its site management & monitoring teams operating from 30 locations on three continents (Asia/Pacific, USA, and Europe), QPS has become a new strong player in Phase II/IV clinical research services.…
Reduce Metal Detector Testing and Reap the Benefits
8 game-changing resources for infectious disease research
6 upcoming webinars to expand your research capacity
Top new resources for greener research
RNAscope Plus smRNA-RNA assay
Advanced Cell DiagnosticsThe RNAscope Plus™ smRNA-RNA assay allows simultaneous detection of 1 smRNA and up to 3 RNA targets within a single sample using up to four target probes.
KAPA DNA Library Preparation Kits for Illumina
Kapa Biosystems, Inc.KAPA DNA Library Preparation Kits for Illumina sequencing platforms contain evolved and optimally formulated enzymes that enable the highest overall coverage from the least amount of total sequencing. Kits are optimized to achieve significantly higher library yields and contain KAPA HiFi for high-fidelity, high-efficiency and low-bias library amplification. This ensures the highest library and sequence data quality, particu…
Spotlight 200i FT-IR Microscopy System with Spectrum Two
PerkinElmerSpotlight 200i FT-IR Microscopy System with Spectrum Two
EVIK DxSpheres - Lyophilized reagent beads
Evik DiagnosticsEVIK™ DxSpheres - A solid assay solution. EVIK DxSpheres are precise-durable spheres, originating from a few uL drops of liquid reagent mix. EVIK helps assay developers solve the common challenge of reagent stability by incorporating reagent(s) into stable lyophilized beads that are versatile for use in micro-fluidic cartridges or other custom devices.
Target Sufficiency
InotivTarget Sufficiency® is the ability of a target system to respond to a therapeutic. It reflects the abundance and forms of the drug target protein, as well as other key system proteins that connect the target to disease phenotypes and enable response. Assessment of the target system requires an analysis platform that can simultaneously capture multiple precise protein measurements.